Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma

F Huemer; L Weiss; P Regitnig; T Winder; C A Schmitt; J Thaler; E Wöll; R Greil

doi:10.1016/j.esmoop.2024.102973

Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma

F Huemer (Erstautor/-in), L Weiss (Co-Autor/-in), P Regitnig, T Winder, C A Schmitt, J Thaler, E Wöll, R Greil^* (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Beitrag in Fachzeitschrift › Letter to the editor › Begutachtung

Originalsprache	Englisch
Aufsatznummer	102973
Seiten (von - bis)	102973
Seitenumfang	2
Fachzeitschrift	ESMO OPEN
Jahrgang	9
Ausgabenummer	4
Frühes Online-Datum	19 März 2024
DOIs	https://doi.org/10.1016/j.esmoop.2024.102973
Publikationsstatus	Veröffentlicht - Apr. 2024

Zugriff auf Dokument

10.1016/j.esmoop.2024.102973

Dieses zitieren

Huemer, F., Weiss, L., Regitnig, P., Winder, T., Schmitt, C. A., Thaler, J., Wöll, E., & Greil, R. (2024). Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma. ESMO OPEN, 9(4), 102973. Artikel 102973. https://doi.org/10.1016/j.esmoop.2024.102973

@article{238ca317a5544d53bf233bcbcb429a0f,

title = "Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma",

author = "F Huemer and L Weiss and P Regitnig and T Winder and Schmitt, {C A} and J Thaler and E W{\"o}ll and R Greil",

note = "Huemer, Weiss, Greil: Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg",

year = "2024",

month = apr,

doi = "10.1016/j.esmoop.2024.102973",

language = "English",

volume = "9",

pages = "102973",

journal = "ESMO OPEN",

issn = "2059-7029",

publisher = "Elsevier ",

number = "4",

}

Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma. / Huemer, F (Erstautor/-in); Weiss, L (Co-Autor/-in); Regitnig, P et al.
in: ESMO OPEN, Jahrgang 9, Nr. 4, 102973, 04.2024, S. 102973.

Publikation: Beitrag in Fachzeitschrift › Letter to the editor › Begutachtung

TY - JOUR

T1 - Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma

AU - Huemer, F

AU - Weiss, L

AU - Regitnig, P

AU - Winder, T

AU - Schmitt, C A

AU - Thaler, J

AU - Wöll, E

AU - Greil, R

N1 - Huemer, Weiss, Greil: Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg

PY - 2024/4

Y1 - 2024/4

U2 - 10.1016/j.esmoop.2024.102973

DO - 10.1016/j.esmoop.2024.102973

M3 - Letter to the editor

C2 - 38507896

SN - 2059-7029

VL - 9

SP - 102973

JO - ESMO OPEN

JF - ESMO OPEN

IS - 4

M1 - 102973

ER -